New research shows diabetes drug could provide brain protection to children who get radiation for brain tumours

Thanks to funding from Medicine by Design, a University of Toronto scientist and her team are closer to finding a way to protect the brain from damage for children who must be treated with cranial radiation.

Pivotal Experiment Fund to accelerate Medicine by Design-funded research toward impact

Medicine by Design's $4-million Pivotal Experiment Fund aims to bridge one of the critical gaps in the “valley of death” between a research discovery and a translatable therapy.

Medicine by Design-funded researchers develop cell injection technique that could help reverse vision loss

The technique could point the way toward new treatments with the potential to reverse forms of vision loss that are currently incurable.

By |2020-09-08T12:08:56-04:00August 19th, 2020|Categories: News|Tags: , , , , |

U of T and SickKids researchers demonstrate drug stimulation of neural stem cell repair leads to promising impact on treatment of childhood brain injury in survivors of brain cancer

Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated

Medicine by Design-funded team uses stem cells to grow functional blood vessel cells found in the liver

Discovery to provide insights into liver development and disease progression

Medicine by Design announces four new team projects

Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.

By |2020-03-04T08:52:07-05:00February 28th, 2020|Categories: Awards, News, Team Projects|Tags: , , , , |
Go to Top